반응식
[CH3:1][N:2]1[C:6]([C:7]([OH:9])=O)=[CH:5][C:4]([CH3:10])=[N:3]1.CN(C)C=O.C(Cl)(=O)C(Cl)=O.[NH2:22][C:23]1[CH:24]=[C:25]([CH:42]=[CH:43][CH:44]=1)[O:26][C:27]1[CH:28]=[CH:29][C:30]2[N:31]([CH:33]=[C:34]([NH:36][C:37](=[O:41])[CH:38]([CH3:40])[CH3:39])[N:35]=2)[N:32]=1>CN(C)C(=O)C.O1CCCC1>[C:37]([NH:36][C:34]1[N:35]=[C:30]2[CH:29]=[CH:28][C:27]([O:26][C:25]3[CH:24]=[C:23]([NH:22][C:7]([C:6]4[N:2]([CH3:1])[N:3]=[C:4]([CH3:10])[CH:5]=4)=[O:9])[CH:44]=[CH:43][CH:42]=3)=[N:32][N:31]2[CH:33]=1)(=[O:41])[CH:38]([CH3:40])[CH3:39]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
Using 1,3-dimethyl-1H-pyrazole-5-carboxylic acid (108 mg, 0.77 mmol), tetrahydrofuran (3.2 mL), N,N-dimethylformamide (30 μL, 0.39 mmol), oxalyl chloride (134 μL, 1.54 mmol), N-[6-(3-aminophenoxy)imidazo[1,2-b]pyridazin-2-yl]-2-methylpropanamide (200 mg, 0.64 mmol) and N,N-dimethylacetamide (4.0 mL) as starting materials and in the same manner as in Example 119, the title compound (201 mg, 72%) was obtained as a white powder.
출처 및 근거
- ORD 기록
- ord-2f597f7bd20142c6ab6c60ff32d9c84d
- 출처 데이터셋
- uspto-grants-2012_09
- 특허 번호
- US08273741B2
연결된 노트
불러오는 중…